C1 Esterase Inhibitor, Antigen
C1 esterase inhibitor (C1 INH) is a serum alpha2 globulin protein that is synthesized in liver hepatocytes, blood monocytes, skin cells, and vascular endothelium. This protein controls the first stage of the classic complement pathway by inhibiting thrombin, plasmin, and kallikrein. Deficiency of this protein results in spontaneous activation of complement components leading to consumption of complement components C2 and C4. C1-INH deficiency is present in acquired and hereditary angioedemas. Angioedema is a rapid swelling of the skin, and skin submucosal tissues. Three variants have been described:
- Hereditary Angioedema I (HAE I): Low C1-INH protein level but normal function (quantitative deficiency; 85% of cases; autosomal dominant)
- HAE II: Normal or elevated protein level but dysfunctional (qualitative defect; 15% of cases; autosomal dominant)
- HAE Type III: recently identified as an estrogen-dependent inherited form of angioedema occurring mainly in women with normal functional and quantitative levels of C1-INH
Acquired angioedema (AAE) is very rare. It may be seen in a number of diseases including certain cancers and is caused by consumption of C1 inhibitor. There are two types of AAE, type 1 due to other diseases, notably certain types of lymphoma, and type 2 due to an autoantibody directed against C1 inhibitor. Patients with HAE may experience recurrent soft tissue swellings, intestinal swellings, abdominal pain, and life threatening swellings of the airway. The most common cause of mortality is acute airway obstruction due to laryngeal edema. In all three forms of HAE levels of C2 and C4 are decreased because of the uncontrolled activity of C1s. The functional assay involves the measurement of C1 INH as it inhibits the hydrolysis of a substrate ester by C1 esterase. Quantitative Immunoassay of C1 INH is also available. Replacement therapy using C1 esterase derived from human blood is available.
- Diagnosis of acquired and hereditary angioedemas
- Differential diagnosis between acquired/hereditary angioedemas and other causes of angioedema such as allergic, idiopathic, cold-induced, angiotensin-converting enzyme (ACE)-associated and nonsteroidal anti-inflammatory drug (NSAID)-associated.
- Treatment monitor and disease management
Decreased in:
- Acquired and hereditary angioedema
Normal in:
- Idiopathic or cold-induced skin swelling
- Angiotensin-converting enzyme (ACE)-associated angioedemas
- Nonsteroidal anti-inflammatory drug (NSAID)-associated angioedema
18-40 mg/dL
Serum separated tube (SST) or Red top tube.
Stability
- Ambient: Unacceptable
- Refrigerated: Unacceptable
- Frozen: 30 days
Note: separate serum within 1 hour of collection and keep frozen.
- Clin Exp Dermatol. 2005;30:460. [PMID: 15953110]
- J Allergy Clin Immunol. 2004 Sep;114(3 Suppl):S51-131 [PMID: 15356535]
- Immunol Allergy Clin North Am. 2006;26:653. [PMID: 17085283]
- Recent Pat Inflamm Allergy Drug Discov. 2008;2(3):166-74. [PMID: 19076006]